125 related articles for article (PubMed ID: 37733966)
1. Prospective Assessment of Loteprednol Etabonate 0.25% for Prevention of Immunologic Rejection After Descemet Membrane Endothelial Keratoplasty in Eyes With Fuchs Dystrophy.
Price MO; Feng MT; Gang A; Price FW
Cornea; 2023 Sep; ():. PubMed ID: 37733966
[TBL] [Abstract][Full Text] [Related]
2. Loteprednol Etabonate 0.5% Gel Vs. Prednisolone Acetate 1% Solution After Descemet Membrane Endothelial Keratoplasty: Prospective Randomized Trial.
Price MO; Feng MT; Scanameo A; Price FW
Cornea; 2015 Aug; 34(8):853-8. PubMed ID: 26020827
[TBL] [Abstract][Full Text] [Related]
3. Descemet's Membrane Endothelial Keratoplasty: Risk of Immunologic Rejection Episodes after Discontinuing Topical Corticosteroids.
Price MO; Scanameo A; Feng MT; Price FW
Ophthalmology; 2016 Jun; 123(6):1232-6. PubMed ID: 26983976
[TBL] [Abstract][Full Text] [Related]
4. Randomized comparison of topical prednisolone acetate 1% versus fluorometholone 0.1% in the first year after descemet membrane endothelial keratoplasty.
Price MO; Price FW; Kruse FE; Bachmann BO; Tourtas T
Cornea; 2014 Sep; 33(9):880-6. PubMed ID: 25062336
[TBL] [Abstract][Full Text] [Related]
5. Graft failure rate and complications after Descemet membrane endothelial keratoplasty in eyes with pre-existing glaucoma.
Maier AB; Pilger D; Gundlach E; Winterhalter S; Torun N; Dietrich-Ntoukas T
Graefes Arch Clin Exp Ophthalmol; 2023 Feb; 261(2):467-476. PubMed ID: 36040539
[TBL] [Abstract][Full Text] [Related]
6. Attenuation of ocular hypertension with the use of topical loteprednol etabonate 0.5% in steroid responders after corneal transplantation.
Holland EJ; Djalilian AR; Sanderson JP
Cornea; 2009 Dec; 28(10):1139-43. PubMed ID: 19770719
[TBL] [Abstract][Full Text] [Related]
7. Long-term Results of Intraocular Pressure Elevation and Post-DMEK Glaucoma After Descemet Membrane Endothelial Keratoplasty.
Maier AB; Pilger D; Gundlach E; Winterhalter S; Torun N
Cornea; 2021 Jan; 40(1):26-32. PubMed ID: 32558736
[TBL] [Abstract][Full Text] [Related]
8. Five-Year Graft Survival of Descemet Membrane Endothelial Keratoplasty (EK) versus Descemet Stripping EK and the Effect of Donor Sex Matching.
Price DA; Kelley M; Price FW; Price MO
Ophthalmology; 2018 Oct; 125(10):1508-1514. PubMed ID: 29731147
[TBL] [Abstract][Full Text] [Related]
9. Preventive treatment of allograft rejection after endothelial keratoplasty: A systematic review and meta-analysis.
Magnier F; Dutheil F; Pereira B; Watson SL; Baker JS; Chiambaretta F; Navel V
Acta Ophthalmol; 2022 Aug; 100(5):e1061-e1073. PubMed ID: 35411680
[TBL] [Abstract][Full Text] [Related]
10. Intraocular pressure elevation and post-DMEK glaucoma following Descemet membrane endothelial keratoplasty.
Maier AK; Wolf T; Gundlach E; Klamann MK; Gonnermann J; Bertelmann E; Joussen AM; Torun N
Graefes Arch Clin Exp Ophthalmol; 2014 Dec; 252(12):1947-54. PubMed ID: 25099676
[TBL] [Abstract][Full Text] [Related]
11. The effect of loteprednol suspension eye drops after corneal transplantation.
Chen Y; Wang X; Gao M; Gao R; Song L
BMC Ophthalmol; 2021 May; 21(1):234. PubMed ID: 34039301
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for intraocular pressure elevation following Descemet membrane endothelial keratoplasty in Asian patients.
Ida Y; Shimizu T; Kuroki T; Mizuki Y; Takeda M; Mizuki N; Yamagami S; Hayashi T
Graefes Arch Clin Exp Ophthalmol; 2023 Mar; 261(3):749-760. PubMed ID: 36123407
[TBL] [Abstract][Full Text] [Related]
13. Impact of the Topical Ophthalmic Corticosteroid Loteprednol Etabonate on Intraocular Pressure.
Sheppard JD; Comstock TL; Cavet ME
Adv Ther; 2016 Apr; 33(4):532-52. PubMed ID: 26984315
[TBL] [Abstract][Full Text] [Related]
14. Risk of corneal transplant rejection significantly reduced with Descemet's membrane endothelial keratoplasty.
Anshu A; Price MO; Price FW
Ophthalmology; 2012 Mar; 119(3):536-40. PubMed ID: 22218143
[TBL] [Abstract][Full Text] [Related]
15. Comparison of Intraocular Pressure, Usage of Topical Steroids, Need for Intraocular Pressure Lowering Drops, and Incidence of Glaucoma Surgery Up to 2 Years After Penetrating Keratoplasty and Endothelial Keratoplasty.
Vu PQ; Aggarwal S; Lu Y; Xie K; Wade M; Bhatt A
J Glaucoma; 2020 Dec; 29(12):1120-1125. PubMed ID: 32826764
[TBL] [Abstract][Full Text] [Related]
16. Descemet Membrane Endothelial Keratoplasty Versus Descemet Stripping Automated Endothelial Keratoplasty and Penetrating Keratoplasty.
Woo JH; Ang M; Htoon HM; Tan D
Am J Ophthalmol; 2019 Nov; 207():288-303. PubMed ID: 31228467
[TBL] [Abstract][Full Text] [Related]
17. Quantitative Assessment of Aqueous Flare After Descemet Membrane Endothelial Keratoplasty for Fuchs Endothelial Dystrophy.
Baydoun L; Chang Lam F; Schaal S; Hsien S; Oellerich S; van Dijk K; Melles GRJ
Cornea; 2018 Jul; 37(7):848-853. PubMed ID: 29547408
[TBL] [Abstract][Full Text] [Related]
18. Does Same-Day Postoperative Increased Intraocular Pressure Affect Endothelial Cell Density After Descemet Membrane Endothelial Keratoplasty?
Fajgenbaum MAP; Hollick EJ
Cornea; 2018 Dec; 37(12):1484-1489. PubMed ID: 30222712
[TBL] [Abstract][Full Text] [Related]
19. Intraocular pressure elevations with loteprednol etabonate: a retrospective chart review.
Rajpal RK; Digby D; D'Aversa G; Mah F; Hollander DA; Conway T
J Ocul Pharmacol Ther; 2011 Jun; 27(3):305-8. PubMed ID: 21574815
[TBL] [Abstract][Full Text] [Related]
20. Causes of glaucoma after descemet membrane endothelial keratoplasty.
Naveiras M; Dirisamer M; Parker J; Ham L; van Dijk K; Dapena I; Melles GR
Am J Ophthalmol; 2012 May; 153(5):958-966.e1. PubMed ID: 22285014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
